Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
VVOS holding history
Vivos Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VVOS overviewAll 13F holders of VVOSFull Q4 2025 holdings
- Shares (Q4 2025)
- 304,161
- Value
- $617.4K
- % of portfolio
- <0.1%
- Quarters held
- 19
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 304,161 | $617.4K | <0.1% | +212,700+232.6% | Added | Holders |
| Q3 2025 | 91,461 | $283.5K | <0.1% | +48,827+114.5% | Added | Holders |
| Q2 2025 | 42,634 | $134.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 42,634 | $121.5K | <0.1% | +32,055+303.0% | Added | Holders |
| Q4 2024 | 10,579 | $45.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 10,579 | $27.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 10,579 | $23.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 10,579 | $51.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 10,579 | $131.6K | <0.1% | −14,022−57.0% | ReducedConverted for a 1-for-25 split | Holders |
| Q3 2023 | 615,015 | $118.1K | <0.1% | −99,091−13.9% | Reduced | Holders |
| Q2 2023 | 714,106 | $364.2K | <0.1% | −5,061−0.7% | Reduced | Holders |
| Q1 2023 | 719,167 | $245.3K | <0.1% | −12,675−1.7% | Reduced | Holders |
| Q4 2022 | 731,842 | $294.2K | <0.1% | +464+0.1% | Added | Holders |
| Q3 2022 | 731,378 | $475.0K | <0.1% | +36,327+5.2% | Added | Holders |
| Q2 2022 | 695,051 | $897.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 695,051 | $1.86M | <0.1% | +31,798+4.8% | Added | Holders |
| Q4 2021 | 663,253 | $1.49M | <0.1% | +46,002+7.5% | Added | Holders |
| Q3 2021 | 617,251 | $2.49M | <0.1% | +233,360+60.8% | Added | Holders |
| Q2 2021 | 383,891 | $1.90M | <0.1% | +383,891 | New | Holders |